Keith Crandell is a co-founder and a Managing Director of ARCH Venture Partners, where his bio describes a focus on life science therapeutics, tools, devices and diagnostics along with specialty materials, electronics, instrumentation and photonics businesses. Before ARCH he worked at Hercules, Inc., a specialty chemical and polymer company. He is currently a director of 908 Devices, Twist Bioscience, Arbor Biotechnologies, Cytrellis Biosystems, Lightcast Discovery, UltraDx and Vizgen, and a board observer at AIRNA, Quantum Circuits and Slingshot Biosciences. He holds an M.B.A. from The University of Chicago, an M.S. in Chemistry from the University of Texas at Arlington and a B.S. in Chemistry and Mathematics from St. Lawrence University.
Education
M.B.A., The University of Chicago
M.S. Chemistry, University of Texas at Arlington
B.S. Chemistry and Mathematics, St. Lawrence University
Previous Experience
Hercules, Inc., a specialty chemical and polymer company